文献速递头颈腹部泌尿生殖MRPETCT

磁共振成像在(未来)肿瘤分期中的作用:关注淋巴结

The Role of Magnetic Resonance Imaging in (Future) Cancer Staging: Note the Nodes.
PubMed 文献 · Invest Radiol · 2021-01-01

本文讨论淋巴结转移是实体瘤重要预后因素,现有N分期方法如淋巴结清扫、形态学CT/MRI或PET-CT因技术、生物学或解剖原因存在明显局限。作者提出USPIO增强MRI可无创鉴别转移与非转移淋巴结,并以头颈癌、食管癌、直肠癌和前列腺癌为例,结合超高场强和运动部位成像等最新方法学进展进行阐述。

要点

  • 淋巴结转移与否是实体瘤的重要预后因素,现有N分期方法存在明显局限。
  • USPIO增强MRI利用超小超顺磁性氧化铁颗粒鉴别转移与非转移淋巴结,可实现无创N分期。
  • 作者以头颈癌、食管癌、直肠癌和前列腺癌为例说明USPIO增强MRI的应用。

核心结论

  • USPIO增强MRI为多种癌症的无创N分期提供了诊断可能,其软组织对比和USPIO对转移与非转移淋巴结的区分可能使治疗更精准、副作用更少。
  • 在寡转移阶段的癌症患者中,USPIO增强MRI可能使治疗更精准、副作用更少。
  • 仍需进一步科学和临床开发,以评估USPIO增强MRI在不同癌种和不同解剖部位检测小转移灶的准确性,并拓宽(USPIO增强)MRI在临床实践淋巴结成像中的适应证。

研究设计与样本

  • 本文为综述性文章,讨论MRI在肿瘤N分期中的作用,未报告系统检索范围与纳入文献数量。
  • 文中以头颈癌、食管癌、直肠癌和前列腺癌4个例子说明USPIO增强MRI用于不同类型癌症N分期的无创诊断可能性。
  • 文中讨论了磁共振方法学最新进展,使USPIO增强MRI可用于超高磁场强度以及上腹部或纵隔等运动部位。
  • 针对前列腺癌,文中将USPIO增强MRI与连接前列腺特异性膜抗原的放射性核素示踪剂进行了比较。
  • 文中还考虑了利用MRI改进离体癌症诊断。

临床应用与阅片要点

  • 作者提出,USPIO增强MRI凭借优异的软组织对比和基于USPIO的转移与非转移淋巴结区分,可能使治疗更精准、副作用更少。
  • 作者认为仍需进一步科学和临床开发,以评估USPIO增强MRI在不同癌种和不同解剖部位检测小转移灶的准确性,并拓宽其临床应用适应证。

局限性

  • 现有用于N分期的侵入性和非侵入性诊断方法如淋巴结清扫、形态学CT/MRI或PET-CT因技术、生物学或解剖原因存在明显局限。
  • 仍需进一步科学和临床开发,以评估USPIO增强MRI在不同癌种和不同解剖部位检测小转移灶的准确性,并拓宽(USPIO增强)MRI在临床实践淋巴结成像中的适应证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The presence or absence of lymph node metastases is a very important prognostic factor in patients with solid tumors. Current invasive and noninvasive diagnostic methods for N-staging like lymph node dissection, morphologic computed tomography/magnetic resonance imaging (MRI), or positron emission tomography-computed tomography have significant limitations because of technical, biological, or anatomical reasons. Therefore, there is a great clinical need for more precise, reliable, and noninvasive N-staging in patients with solid tumors. Using ultrasmall superparamagnetic particles of ironoxide (USPIO)-enhanced MRI offers noninvasive diagnostic possibilities for N-staging of different types of cancer, including the 4 examples given in this work (head and neck cancer, esophageal cancer, rectal cancer, and prostate cancer). The excellent soft tissue contrast of MRI and an USPIO-based differentiation of metastatic versus nonmetastatic lymph nodes can enable more precise therapy and, therefore, fewer side effects, essentially in cancer patients in oligometastatic disease stage. By discussing 3 important questions in this article, we explain why lymph node staging is so important, why the timing for more accurate N-staging is right, and how it can be done with MRI. We illustrate this with the newest developments in magnetic resonance methodology enabling the use of USPIO-enhanced MRI at ultrahigh magnetic field strength and in moving parts of the body like upper abdomen or mediastinum. For prostate cancer, a comparison with radionuclide tracers connected to prostate specific membrane antigen is made. Under consideration also is the use of MRI for improvement of ex vivo cancer diagnostics. Further scientific and clinical development is needed to assess the accuracy of USPIO-enhanced MRI of detecting small metastatic deposits for different cancer types in different anatomical locations and to broaden the indications for the use of (USPIO-enhanced) MRI in lymph node imaging in clinical practice.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Scheenen TWJ, Zamecnik P. The Role of Magnetic Resonance Imaging in (Future) Cancer Staging: Note the Nodes. Invest Radiol. 2021. PMID: 33156126. doi:10.1097/RLI.0000000000000741

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。